Pantoprazol Aurobindo (Pantoprazole)

Pantoprazol Aurobindo is a proton pump inhibitor that addresses disorders linked to excess gastric acid secretion.

• Gastro‑esophageal reflux disease (GERD): provides symptomatic relief and promotes healing of erosive esophagitis.
• Peptic ulcer disease: supports ulcer healing and reduces recurrence risk.
• Zollinger‑Ellison syndrome: controls gastric acid hypersecretion associated with gastrin‑producing tumors.
• NSAID‑induced ulcer prophylaxis: lowers the risk of ulcer formation in patients requiring long‑term NSAID therapy.

• Pantoprazole selectively inhibits the H+/K+‑ATPase enzyme (the gastric proton pump) located on the secretory surface of parietal cells. By binding covalently to the pump’s cysteine residues, it blocks the final step of acid secretion, leading to a sustained increase in gastric pH and reduced acidity in the stomach lumen.

Pantoprazol Aurobindo may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects

• Headache: mild, transient headache reported by some patients.
• Diarrhea: loose stools occurring during early treatment.
• Nausea: occasional feeling of queasiness.
• Abdominal pain: mild discomfort in the stomach area.
• Flatulence: increased gas formation.
• Constipation: reduced bowel movements.

Serious or Rare Side Effects

• Severe allergic reaction: rash, itching, swelling, or difficulty breathing.
• Clostridioides difficile infection: persistent watery diarrhea with abdominal cramping.
• Low magnesium levels: muscle cramps, irregular heartbeat, or seizures.
• Bone fracture risk: increased susceptibility to hip, wrist, or spine fractures with long‑term use.
• Acute interstitial nephritis: kidney inflammation presenting as fever, rash, and reduced urine output.
• Hepatotoxicity: elevated liver enzymes or jaundice.

Before initiating therapy with Pantoprazol Aurobindo, consider the following precautions:

• Assess renal function: dosage adjustment may be required in severe renal impairment.
• Evaluate hepatic status: use with caution in patients with liver disease.
• Review long‑term use: prolonged therapy may be linked to nutrient malabsorption and bone density loss.
• Monitor for infections: increased risk of gastrointestinal infections such as C. difficile.
• Pregnancy and lactation: weigh potential benefits against risks; consult a healthcare professional.
• Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Pantoprazol Aurobindo can affect the pharmacokinetics of several co‑administered medicines. Careful review of a patient’s medication list is recommended.

Major Interactions (Avoid)

• Antifungal agents (ketoconazole, itraconazole): reduced absorption leading to therapeutic failure.
• HIV protease inhibitors (atazanavir, nelfinavir): decreased plasma concentrations.
• Clopidogrel: diminished antiplatelet effect, increasing cardiovascular risk.

Moderate Interactions (Monitor Closely)

• Warfarin: potential increase in INR; monitor coagulation parameters.
• Methotrexate: possible accumulation and toxicity, especially at high doses.
• Digoxin: modest rise in serum levels; observe for signs of digoxin toxicity.